National Capital Clinical Research Consortium is a clinical research site located in Bethesda, Maryland, United States 20817.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
National Capital Clinical Research Consortium has participated in 16 clinical trials.
Therapeutic areas: Multiple Myeloma, Non Small Cell Lung Cancer, Chronic Lymphocytic Leukemia.
Sponsors: SCRI Development Innovations, LLC.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
National Capital Clinical Research Consortium has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
National Capital Clinical Research Consortium has 16 clinical trials on record. Their work covers Multiple Myeloma, Non Small Cell Lung Cancer, Chronic Lymphocytic Leukemia.
Yes — National Capital Clinical Research Consortium holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.